Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Stomatitis 3 Head and Neck Neoplasms 3 Fatigue 3 Colorectal Neoplasms 3 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Ulcer 1 Trauma, Nervous System 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Schwannomatosis 1 Rectal Neoplasms 1 Psoriasis 1 Pleural Effusion, Malignant 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Non-functioning Pituitary Adenoma 1 Neurofibromatosis 1 1 Neurilemmoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Mesothelioma 1 Malignant Neoplasm of Colorectum 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1

Interventions

Paclitaxel 5 Carboplatin 5 Docetaxel 4 Cisplatin 4 Bevacizumab 4 Taxes 3 Drug Therapy 3 Gemcitabine 2 Fluorodeoxyglucose F18 2 Cetuximab 2 saracatinib 1 endostar protein 1 cediranib 1 aflutinib 1 Zoledronic Acid 1 X-Rays 1 Vinorelbine 1 Thoracic Surgery, Video-Assisted 1 Spectrum Analysis 1 Silver Nitrate 1 Saline Solution 1 Radiotherapy, Conformal 1 Radiation 1 Pleurodesis 1 Pemetrexed 1 Nivolumab 1 Naproxen 1 N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1 Morphine 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pleural Effusion, Malignant × Saline Solution × Clear all

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡